A new study has found a connection between certain diabetes medications and the development of multiple sclerosis. This is the first study to identify a specific link between the two conditions.
The study, which was published in the journal Neurology, looked at data from the U.K. General Practice Research Database. The database included information on patients with diabetes who had been prescribed either metformin or pioglitazone. The researchers then looked at the records of these patients to see if they had been diagnosed with multiple sclerosis.
The study found that patients who had been prescribed metformin were slightly less likely to develop multiple sclerosis than those who had not been prescribed the medication. However, patients who had been prescribed pioglitazone were actually slightly more likely to develop multiple sclerosis than those who had not been prescribed the medication.
The study did not find a causal link between the diabetes medications and the development of multiple sclerosis. However, the findings do suggest that there may be a connection between the two conditions. Further research is needed to confirm these findings and to determine the exact nature of the connection.
A new study has identified a possible connection between diabetes medications and multiple sclerosis (MS).
The study, which was conducted by researchers at the University of British Columbia, looked at the medical records of nearly 3,000 people with MS and compared them to those of more than 27,000 people without the disease.
The researchers found that people who had been prescribed medications for Type 2 diabetes were more than twice as likely to develop MS as those who had not been prescribed these medications.
While the study does not prove that diabetes medications cause MS, the researchers say that the findings suggest that there may be a link between the two conditions.
The findings have been published in the journal Neurology.
